The International Association of Parkinsonism and Related Disorders world congress will be held in Lyon, France on 19-22 August. Dr. Stephen Shrewsbury, CMO will be presenting a poster on A Phase IIa, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Safety and Pharmacokinetic/Pharmacodynamic (PK/PDyn) Study of INP103 (POD® L dopa) Administered in the presence of Benserazide, to L-dopa Responsive Parkinson’s Disease (PD) Patients (THOR 201). He will be available at the poster during the following times:
- Monday, August 20, 2018, from 12.15 – 1.15 pm
- Tuesday, August 21, 2018, from 12.15 – 1.15 pm
For more information, visit the event webpage here.
More than fifty years ago, the International Association of Parkinsonism and Related Disorders was established by the World Federation of Neurology to promote and monitor research developments, as well as to foster communication among neuroscientists in the field. Today, this association is an international, professional association of clinicians, scientists and other healthcare professionals who are interested in neurodegenerative disorders like Parkinson‘s disease, secondary parkinsonisms, hyperkinetic and hypokinetic movement disorders, and more generally any disorder affecting muscle tone and motor control.